The increasingly crowded and complex biologics space is evolving faster than the ability of companies to manage sequence information to secure and protect their valuable IP assets. Missing critical sequence information during biologics R&D can delay progress and result in weaker patent claims, missed opportunity, and greater legal risks.
Join us on Thursday, June 22, 2023, at 12:00 PM ET, for a webinar with IPWatchdog as our panel of industry experts discusses these challenges and ways to use quality sequence data more effectively to build better biologics patents and a stronger patent portfolio. Our panel will include Gene Quinn, IPWatchdog Founder, President & CEO, Anne Marie Clark, Ph.D., Senior Scientist at CAS IP ServicesSM, Ronald C. Kern, Jr., Ph.D., Esq., Partner at BakerHostetler, and Constantine Linnik, Ph.D., JD, CEO of IPSupra, PLLC.
During this webinar, the panel will discuss:
At CAS, we curate, connect, and analyze scientific knowledge to reveal the unseen connections that inspire breakthroughs. We weave a fabric of discovery that scientific innovators can tap into to stimulate their creativity and accelerate their work. Because when the world turns to science, science turns to CAS. So if you’re advancing research, repurposing technology, making strategic decisions, or leading digital R&D initiatives, take a look at our story below to see how partnering with us gets you there faster. A global company based in Columbus, Ohio, CAS employs over 1,400 experts who curate, connect, and analyze scientific knowledge to reveal unseen connections. CAS is a division of the American Chemical Society. Connect with us at cas.org.